Omnicomm Systems Inc (OMCM) 0.1700 $OMCM
OmniComm Systems(R) Announces New Release of TrialOne(R)
Marketwire - Mon Apr 21, 7:36AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, announced the general availability of TrialOne version 4.3. TrialOne is a browser-based, mobile, clinic automation solution designed specifically for early-phase research that facilitates subject recruitment, source data capture, sample tracking, data management and reporting. TrialOne offers time-based data entry and automates many data collection activities via its ability to both print and scan barcodes, as well as to integrate directly with medical monitoring and laboratory equipment. Furthermore, TrialOne's import and export features provide integration with laboratory information management systems for lab orders and results processing.
Quintiles(R) Transnational Signs Five Year Agreement for OmniComm Systems'
R) TrialOne(R)
Marketwire - Wed Apr 16, 7:31AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced the signing of a five year agreement with Quintiles Transnational (Quintiles) for OmniComm Systems' market leading TrialOne technology for Phase I clinic automation. Quintiles is the world's largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries.
Surrey Clinical Research Centre Signs a Five Year Agreement for OmniComm Systems' R) Promasys(R) Software
Marketwire - Mon Apr 14, 7:03AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) a leading global provider of clinical data management solutions for clinical trials, announced the signing of a five year agreement for its Promasys investigator initiated trials (IITs) technology with Surrey Clinical Research Centre (Surrey CRC) at the University of Surrey, a UK based research center focused on the design and execution of Phase I and IIa trials in sleep, psychopharmacology, oncology, immunology and vaccines.
Leading Specialty Pharmaceutical Company Selects OmniComm Systems(R), Inc. TrialMaster(R) to Support Novel Medical Research
Marketwire - Mon Apr 07, 6:01AM CDT
A leading US specialty pharmaceutical company focused on the development and commercialization of novel medicines has selected OmniComm Systems, Inc.'s (OTCQB: OMCM), TrialMaster for three clinical studies comprising a Phase II, Phase III, and safety and pharmacokinetic study.
OmniComm Systems expands market presence in Asia
M2 - Fri Apr 04, 7:00AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said it has signed a five-year agreement with Seoul National University Hospital Clinical Trials Center to use OmniComm Systems' market leading TrialOne technology for automation within its Phase I clinical pharmacology studies.
OmniComm(R) Systems Announces Major Milestone Achievement of Over 4,000 Clinical Trials
Marketwire - Tue Mar 25, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced its electronic data capture (EDC) solutions have been used in more than 4,000 live or completed clinical trials in over 55 countries across more than 30 therapeutic areas. The company's EDC solutions are widely accepted and utilized by pharmaceutical; biotechnology; contract research organizations; academic research centers and medical device companies of all sizes in all clinical trial phases. OmniComm's EDC technologies are embraced by the industry by significantly streamlining clinical processes through innovation, automation and interoperability.
Centre for Human Drug Research Selects OmniComm(R) Promasys(R) Mobile Technology
Marketwire - Wed Mar 19, 6:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a five year agreement with Centre for Human Drug Research (CHDR), a clinical research center in The Netherlands, for Promasys mobile electronic data capture (EDC) technology. This agreement gives CHDR the ability to capture data right at the point-of-clinical testing utilizing the latest in mobile technology.
OmniComm(R) Systems Signs $2.5 Million Deal With Major Biotechnology Company
Marketwire - Mon Mar 17, 1:41PM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a $2.5 million contract for one Phase II and four Phase III global studies with a major east coast biotechnology company to supply OmniComm's market leading electronic data capture (EDC) technology, TrialMaster 4.2. TrialMaster EDC was selected in part for its award-winning Custom Data Export Utility. This enables compliance with FDA's, soon to be mandated, requirement for all clinical data submissions to conform to the Study Data Tabulation Model (SDTM). Conventional methodologies, used for clinical data submission, are very costly and typically take months to complete. TrialMaster's Custom Data Export Utility significantly decreases time to submission and can have SDTM data sets ready within 48 hours of database lock. TrialMaster's unique capability converts clinical study data to SDTM formats during trial conduct in real time, resulting in lower costs, decreased cycle times, and reduced rework.
OmniComm Systems, Inc. Announces Major New Release of TrialMaster(R) EDC
GlobeNewswire - Mon Dec 30, 11:28AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced the production availability of Version 4.2 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This new release includes hundreds of innovative productivity and functionality enhancements, including additional features for auto-redaction for faster and more efficient centralized and risked-based monitoring, and major new features for exporting data utilizing OmniComm's award winning Export Utility.
OmniComm Systems Ranks Number 481 on Deloitte's 2013 Technology Fast 500(TM) for Fastest Growing Companies in North America
GlobeNewswire - Thu Dec 26, 10:55AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced that it was ranked number 481 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America over the past 5 years. OmniComm Systems' revenue grew 148 percent over this period.
OmniComm Systems, Inc. Celebrates Innovation and Excellence at Third Annual Innovation Forum
GlobeNewswire - Fri Nov 22, 7:30AM CST
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, celebrated innovation and excellence at their annual Innovation Forum in Ft. Lauderdale last week.
OmniComm Systems, Inc. Acquires Promasys BV
GlobeNewswire - Tue Nov 12, 7:30AM CST
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced the acquisition of Promasys BV, a privately held Netherlands based company dedicated to the development and marketing of clinical trial software and related services designed specifically for academic research and investigator initiated trials.
OmniComm Bolsters Organization With Addition of Two Industry Experts
GlobeNewswire - Mon Nov 11, 11:45AM CST
John Fontenault Joins as Vice President of Operations
Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
PRWeb - Wed Sep 04, 9:03AM CDT
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with OmniComm Systems, Inc., a leading provider of EDC solutions.
Top 5 Pharma Company Chooses OmniComm System's TrialMaster(R) EDC Solution for Late Phase Research
GlobeNewswire - Wed Aug 14, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster(R) EDC solution has been selected by a top 5 pharmaceutical company to run a 5 year late-phase, non-interventional oncology trial.
Inflamax Research commits to use OmniComm eClinical Suite
M2 - Wed Jul 10, 10:09AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said that Inflamax Research has made a five-year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
Inflamax Research Selects OmniComm Systems' eClinical Suite to Enhance Clinical Operations
GlobeNewswire - Tue Jul 09, 8:03AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Inflamax Research, a full service Contract Research Organization (CRO), has made a 5 year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development
GlobeNewswire - Mon Jun 24, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.
OmniComm Systems, Inc. and Soltex Consulting, LLP Announce a Strategic Partnership
GlobeNewswire - Mon Jun 17, 8:05AM CDT
OmniComm Systems, Inc. (OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Soltex Consulting, LLP, a leading eClinical lifecycle consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer best-in-class process reengineering and change management consulting to its EDC software customers, and augment OmniComm's own study build services, while allowing Soltex to offer its clients access to one of the most intuitive, productive EDC suites available on the market today.
E-Clinical Trial Technologies: Oracle Dominates - Global Strategic Business Report 2013-2018
M2 - Fri Jun 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dsxrd3/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Product Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), mElectronic Patient Reported Outcome (ePRO), Randomization and Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 112 companies including many key and niche players such as: - Almac Group - ArisGlobal LLC - BioClinica - Clinipace Worldwide - Cmed Technology Ltd. - DATATRAK International, Inc. - DSG Inc. - DZS Software Solutions, Inc. - eClinForce, Inc. - e
OmniComm Systems(R) Announces New Release of TrialOne(R)
Marketwire - Mon Apr 21, 7:36AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, announced the general availability of TrialOne version 4.3. TrialOne is a browser-based, mobile, clinic automation solution designed specifically for early-phase research that facilitates subject recruitment, source data capture, sample tracking, data management and reporting. TrialOne offers time-based data entry and automates many data collection activities via its ability to both print and scan barcodes, as well as to integrate directly with medical monitoring and laboratory equipment. Furthermore, TrialOne's import and export features provide integration with laboratory information management systems for lab orders and results processing.
Quintiles(R) Transnational Signs Five Year Agreement for OmniComm Systems'
R) TrialOne(R) Marketwire - Wed Apr 16, 7:31AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced the signing of a five year agreement with Quintiles Transnational (Quintiles) for OmniComm Systems' market leading TrialOne technology for Phase I clinic automation. Quintiles is the world's largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries.
Surrey Clinical Research Centre Signs a Five Year Agreement for OmniComm Systems'
R) Promasys(R) Software Marketwire - Mon Apr 14, 7:03AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) a leading global provider of clinical data management solutions for clinical trials, announced the signing of a five year agreement for its Promasys investigator initiated trials (IITs) technology with Surrey Clinical Research Centre (Surrey CRC) at the University of Surrey, a UK based research center focused on the design and execution of Phase I and IIa trials in sleep, psychopharmacology, oncology, immunology and vaccines.
Leading Specialty Pharmaceutical Company Selects OmniComm Systems(R), Inc. TrialMaster(R) to Support Novel Medical Research
Marketwire - Mon Apr 07, 6:01AM CDT
A leading US specialty pharmaceutical company focused on the development and commercialization of novel medicines has selected OmniComm Systems, Inc.'s (OTCQB: OMCM), TrialMaster for three clinical studies comprising a Phase II, Phase III, and safety and pharmacokinetic study.
OmniComm Systems expands market presence in Asia
M2 - Fri Apr 04, 7:00AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said it has signed a five-year agreement with Seoul National University Hospital Clinical Trials Center to use OmniComm Systems' market leading TrialOne technology for automation within its Phase I clinical pharmacology studies.
OmniComm(R) Systems Announces Major Milestone Achievement of Over 4,000 Clinical Trials
Marketwire - Tue Mar 25, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced its electronic data capture (EDC) solutions have been used in more than 4,000 live or completed clinical trials in over 55 countries across more than 30 therapeutic areas. The company's EDC solutions are widely accepted and utilized by pharmaceutical; biotechnology; contract research organizations; academic research centers and medical device companies of all sizes in all clinical trial phases. OmniComm's EDC technologies are embraced by the industry by significantly streamlining clinical processes through innovation, automation and interoperability.
Centre for Human Drug Research Selects OmniComm(R) Promasys(R) Mobile Technology
Marketwire - Wed Mar 19, 6:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a five year agreement with Centre for Human Drug Research (CHDR), a clinical research center in The Netherlands, for Promasys mobile electronic data capture (EDC) technology. This agreement gives CHDR the ability to capture data right at the point-of-clinical testing utilizing the latest in mobile technology.
OmniComm(R) Systems Signs $2.5 Million Deal With Major Biotechnology Company
Marketwire - Mon Mar 17, 1:41PM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a $2.5 million contract for one Phase II and four Phase III global studies with a major east coast biotechnology company to supply OmniComm's market leading electronic data capture (EDC) technology, TrialMaster 4.2. TrialMaster EDC was selected in part for its award-winning Custom Data Export Utility. This enables compliance with FDA's, soon to be mandated, requirement for all clinical data submissions to conform to the Study Data Tabulation Model (SDTM). Conventional methodologies, used for clinical data submission, are very costly and typically take months to complete. TrialMaster's Custom Data Export Utility significantly decreases time to submission and can have SDTM data sets ready within 48 hours of database lock. TrialMaster's unique capability converts clinical study data to SDTM formats during trial conduct in real time, resulting in lower costs, decreased cycle times, and reduced rework.
OmniComm Systems, Inc. Announces Major New Release of TrialMaster(R) EDC
GlobeNewswire - Mon Dec 30, 11:28AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced the production availability of Version 4.2 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This new release includes hundreds of innovative productivity and functionality enhancements, including additional features for auto-redaction for faster and more efficient centralized and risked-based monitoring, and major new features for exporting data utilizing OmniComm's award winning Export Utility.
OmniComm Systems Ranks Number 481 on Deloitte's 2013 Technology Fast 500(TM) for Fastest Growing Companies in North America
GlobeNewswire - Thu Dec 26, 10:55AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced that it was ranked number 481 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America over the past 5 years. OmniComm Systems' revenue grew 148 percent over this period.
OmniComm Systems, Inc. Celebrates Innovation and Excellence at Third Annual Innovation Forum
GlobeNewswire - Fri Nov 22, 7:30AM CST
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, celebrated innovation and excellence at their annual Innovation Forum in Ft. Lauderdale last week.
OmniComm Systems, Inc. Acquires Promasys BV
GlobeNewswire - Tue Nov 12, 7:30AM CST
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced the acquisition of Promasys BV, a privately held Netherlands based company dedicated to the development and marketing of clinical trial software and related services designed specifically for academic research and investigator initiated trials.
OmniComm Bolsters Organization With Addition of Two Industry Experts
GlobeNewswire - Mon Nov 11, 11:45AM CST
John Fontenault Joins as Vice President of Operations
Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
PRWeb - Wed Sep 04, 9:03AM CDT
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with OmniComm Systems, Inc., a leading provider of EDC solutions.
Top 5 Pharma Company Chooses OmniComm System's TrialMaster(R) EDC Solution for Late Phase Research
GlobeNewswire - Wed Aug 14, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster(R) EDC solution has been selected by a top 5 pharmaceutical company to run a 5 year late-phase, non-interventional oncology trial.
Inflamax Research commits to use OmniComm eClinical Suite
M2 - Wed Jul 10, 10:09AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said that Inflamax Research has made a five-year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
Inflamax Research Selects OmniComm Systems' eClinical Suite to Enhance Clinical Operations
GlobeNewswire - Tue Jul 09, 8:03AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Inflamax Research, a full service Contract Research Organization (CRO), has made a 5 year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.
OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development
GlobeNewswire - Mon Jun 24, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.
OmniComm Systems, Inc. and Soltex Consulting, LLP Announce a Strategic Partnership
GlobeNewswire - Mon Jun 17, 8:05AM CDT
OmniComm Systems, Inc. (OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Soltex Consulting, LLP, a leading eClinical lifecycle consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer best-in-class process reengineering and change management consulting to its EDC software customers, and augment OmniComm's own study build services, while allowing Soltex to offer its clients access to one of the most intuitive, productive EDC suites available on the market today.
E-Clinical Trial Technologies: Oracle Dominates - Global Strategic Business Report 2013-2018
M2 - Fri Jun 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dsxrd3/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Product Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), mElectronic Patient Reported Outcome (ePRO), Randomization and Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 112 companies including many key and niche players such as: - Almac Group - ArisGlobal LLC - BioClinica - Clinipace Worldwide - Cmed Technology Ltd. - DATATRAK International, Inc. - DSG Inc. - DZS Software Solutions, Inc. - eClinForce, Inc. - e
